insights_auto
Why is EDIT down 13,82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,87 US$
arrow_downward
-13,82%(-0,30) 1D
1,91 US$
arrow_upward
+2,14% (+0,040)bedtimeAfter hours
Closed: 16 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
41 წუთის წინ
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
15 საათის წინ
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
13 საათის წინ
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
8 საათის წინ
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc